Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease

NCT05914506 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT05914506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05914506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Active, not recruiting
Start date
October 5, 2023
Completion date
May 1, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

progressive fibrosing interstitial lung disease